Search
Cancer Types
Immunotherapy for Ovarian Cancer
Research
Roswell Park-University of Chicago Ovarian Cancer SPORE Clinical Trials
Page with Layout
Faculty Mentors
… Sai Yendamuri, MD, MBA, FACS Thoracic Surgery Emese Zsiros, MD, PhD, FACOG Gynecologic Oncology Oncology …
Blog Post
Does your gut biome affect your response to immunotherapy?
News
Roswell Park Community Comes Together to Celebrate Outstanding Physicians
Clinical Trial
Randomized Phase 2 Clinical Trial of Pembrolizumab Combined with Bevacizumab with or without Agonist Anti-CD40 CDX-1140 in Patients with Recurrent Ovarian Cancer
Department of Immunology Faculty
… Professor of Oncology Department of Immunology Emese Zsiros, MD, PhD, FACOG Professor of Oncology Co-Leader, Tumor …
Blog Post
Coping with hair loss: Jerrolynn's story
Clinical Trial
Randomized Phase 2 Trial of APL-2 with Pembrolizumab vs. APL-2 with Pembrolizumab and Bevacizumab vs. Bevacizumab alone in Patients with Recurrent Ovarian Cancer and Persistent Malignant Effusion
Tumor Immunology & Immunotherapy Program Members
… Chair, Department of Immunology View the Abrams Lab Emese Zsiros, MD, PhD, FACOG Professor of Oncology Co-Leader, Tumor …